AA
GBT

Ancora Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Ancora Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,050
Closed -$34K – 2474
2022
Q2 		$34K Hold
1,050
– – ﹤0.01% 1294
2022
Q1 		$36K Hold
1,050
– – ﹤0.01% 1381
2021
Q4 		$31K Hold
1,050
– – ﹤0.01% 1444
2021
Q3 		$27K Hold
1,050
– – ﹤0.01% 1391
2021
Q2 		$37K Hold
1,050
– – ﹤0.01% 1192
2021
Q1 		$43K Hold
1,050
– – ﹤0.01% 1119
2020
Q4 		$45K Hold
1,050
– – ﹤0.01% 902
2020
Q3 		$58K Hold
1,050
– – ﹤0.01% 820
2020
Q2 		$66K Hold
1,050
– – ﹤0.01% 778
2020
Q1 		$54K Buy
+1,050
New +$70.3K ﹤0.01% 871

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ancora Advisors's GBT Position: Q3 2022 in Review

Ancora Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 1,050 shares — an estimated $34K sold.

Ancora Advisors first reported a position in GBT in Q1 2020 and held it in 10 quarters. The position peaked at $66K in Q2 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Ancora Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 1,050 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $34K.
  • Ancora Advisors first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 10 quarters.
  • Ancora Advisors's Global Blood Therapeutics, Inc. position peaked at $66K in Q2 2020.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.